FluoGuide A/S (STO:FLUO)
44.10
-0.40 (-0.90%)
Jun 12, 2026, 4:51 PM CET
Chevron Lubricants Lanka Revenue
FluoGuide had revenue of 54.00K DKK in the quarter ending March 31, 2026, with 50.00% growth. This brings the company's revenue in the last twelve months to 238.00K, down -39.75% year-over-year. In the year 2025, FluoGuide had annual revenue of 220.00K, down -42.86%.
Revenue (ttm)
238.00K DKK
Revenue Growth
-39.75%
P/S Ratio
2,063.44
Revenue / Employee
35.52K DKK
Employees
7
Market Cap
721.00M LKR
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220.00K | -165.00K | -42.86% |
| Dec 31, 2024 | 385.00K | -38.00K | -8.98% |
| Dec 31, 2023 | 423.00K | -6.09M | -93.50% |
| Dec 31, 2022 | 6.51M | -3.10M | -32.27% |
| Dec 31, 2021 | 9.61M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| Sprint Bioscience AB | 153.28M |
| Genovis AB (publ.) | 131.09M |
| Oncopeptides AB | 83.24M |
| Intervacc AB | 18.89M |
| Corline Biomedical AB | 10.67M |
| Medivir AB | 9.01M |
| Xspray Pharma AB | 2.47M |
FluoGuide News
- 17 days ago - FluoGuide Earnings Call Transcript: Q1 2026 - Transcripts
- 17 days ago - FluoGuide Quarterly report: Q1 2026 - Filings
- 3 months ago - FluoGuide Earnings Call Transcript: Q4 2025 - Transcripts
- 3 months ago - FluoGuide Annual report: Q4 2025 - Filings
- 3 months ago - FluoGuide Quarterly report: Q4 2025 - Filings
- 5 months ago - FluoGuide Slides: SEB Nordic Seminar presentation - Filings
- 7 months ago - FluoGuide Quarterly report: Q3 2025 - Filings
- 9 months ago - FluoGuide Transcript: Investing in Life Science 2025 - Transcripts